Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

BSH 2019 | CyTOF flow cytometry in determining daratumumab response in myeloma

“Cytometry by Time of Flight (CyTOF) does not depend on the detection of fluorescence, but on the use of elemental metal isotopes conjugated to monoclonal antibodies. Francesca Gay, MD, PhD, University of Turin, Turin, Italy, discusses this platform, particularly its use in determining specific cellular mechanisms in the delevopment of treatment resistance, at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.